The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology Ann-Charlotte EklöfAnn-Mari ThureliusFolke Sjöqvist Special Article 12 September 2003 Pages: 571 - 577
A preliminary report on the application of noscapine in the treatment of stroke Massoud MahmoudianMassoud MehrpourZahra Siadatpour Clinical Trials 27 September 2003 Pages: 579 - 581
Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity M. CamusG. HenneréR. Farinotti Pharmacodynamics 19 September 2003 Pages: 583 - 587
Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects Kazuishi SekinoTakahiro KubotaTatsuji Iga Pharmacodynamics 19 September 2003 Pages: 589 - 592
Testing for benzodiazepine inebriation—relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers Jørgen G. BramnessSvetlana SkurtveitJørg Mørland Pharmacodynamics 20 September 2003 Pages: 593 - 601
Pharmacokinetic–pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide Pedro SilveiraManuel Vaz-da-SilvaPatrício Soares-da-Silva Pharmacodynamics 27 September 2003 Pages: 603 - 609
Concordance between proguanil phenotype andCYP2C19 genotype in Chinese Janelle M. HoskinsGillian M. ShenfieldAnnette S. Gross Pharmacogenetics 12 September 2003 Pages: 611 - 614
The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers Manami OdaTsutomu KotegawaShigeyuki Nakano Pharmacokinetics and Disposition 27 September 2003 Pages: 615 - 619
Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers Margherita Strolin BenedettiRhys WhomsleyEugène Baltes Pharmacokinetics and Disposition 07 October 2003 Pages: 621 - 630
A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations Christian JoukhadarBarbara SchenkHans-Georg Eichler Pharmacokinetics and Disposition 17 October 2003 Pages: 631 - 636
Changes in drug treatment in the elderly between 1971 and 2000 B. LernfeltO. SamuelssonS. Landahl Pharmacoepidemiology and Prescription 16 August 2003 Pages: 637 - 644
"Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs Kathleen BennettMary TeelingJohn Feely Pharmacoepidemiology and Prescription 27 August 2003 Pages: 645 - 649
Exploring patient- and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care Giampiero MazzagliaAchille P. CaputiClaudio Cricelli Pharmacoepidemiology and Prescription 12 September 2003 Pages: 651 - 657
Statin compliance in the Umbrian population Iosief AbrahaAlessandro MontedoriCarlo Romagnoli Pharmacoepidemiology and Prescription 24 September 2003 Pages: 659 - 661
Urinary tract infection in women—physician's preferences for treatment and adherence to guidelines: a national drug utilization study in a managed care setting Ernesto KahanNatan R. KahanDavid P. Chinitz Pharmacoepidemiology and Prescription 27 September 2003 Pages: 663 - 668
Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status Ing-Britt HolmquistBengt SvenssonPeter Höglund Pharmacoepidemiology and Prescription 27 September 2003 Pages: 669 - 676
Prescription and non-prescription medicine use in Denmark: association with socio-economic position Merete W. NielsenEbba Holme HansenNiels Kristian Rasmussen Pharmacoepidemiology and Prescription 02 October 2003 Pages: 677 - 684
Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists J. L. MontastucV. BongardM. Lapeyre-Mestre Pharmacoepidemiology and Prescription 11 October 2003 Pages: 685 - 688
Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999 Laurence Guédon-MoreauDominique DucrocqJacques Caron Pharmacoepidemiology and Prescription 14 October 2003 Pages: 689 - 695
Error reduction: academic detailing as a method to reduce incorrect prescriptions J. ShawP. HarrisP. S. Thomas Pharmacoepidemiology and Prescription 18 October 2003 Pages: 697 - 699
Efficacy, safety and cost of new cardiovascular drugs: a survey Silvio GarattiniVittorio Bertele' Opinion Paper 05 September 2003 Pages: 701 - 706
Allele and genotype frequency of CYP2C9 in Tamilnadu population C. AdithanN. GerardR. Krishnamoorthy Short Communication 19 September 2003 Pages: 707 - 709
The delusion of reducing sample size Bernard BégaudAnnie FourrierYola Moride Letter to the Editors 18 October 2003 Pages: 711 - 712